Directive 2005/29/EC (as amended by Directive 2024/825/EU) is a lex generalis and serves as a “safety net” to protect consumers from any misleading commercial practices. It applies in principle to all products/services and thus also to over-the-counter medicines that are products purchased by consumers for personal use. Obviously, the Directive will complement specific regulations relating to the marketing of specific products that will prevail (as lex specialis) in case of conflict.
Last modified on 09/01/2025